- State sees dip in mucormycosis cases
With the second wave of COVID-19 subsiding, Karnataka is also witnessing a steady decline in mucormycosis cases. The State that added a total of 207 mucormycosis cases since July 5, has recorded only 51 cases in the last six days. Besides, there have been zero admissions in Bengaluru’s designated government hospitals in the last two days.
- Even one vaccine dose reduces infection severity, mortality
A study conducted by a leading private hospital in Bengaluru has found that the mortality rate among Covid-19 patients was much higher among people who did not take even one dose of the vaccine as against those who did.
- Covid antibodies last at least 9 months after infection
Antibody levels remain high nine months after infection with SARS-CoV-2, the virus that causes Covid-19, whether symptomatic or asymptomatic, according to a study published on Monday that analysed data from an entire Italian town.
- SSLC exam: 99.6% attend, results in Aug 2nd week
Nearly 8.5 lakh students turned up for the SSLC exam on Monday, a better turnout than last year. Monday’s was the first of two papers with the second — on languages — scheduled for Thursday.
- In tussle between school managements and parents, many miss SSLC exam
Many students missed the SSLC examination that kicked off on Monday. The reason being some school managements denying admission tickets to students who were unable to pay the fees during the pandemic-hit year.
- Good response to reopening of medical and dental colleges
There was good turnout of students in medical and dental colleges as offline classes reopened on Monday. The colleges were closed in March due to the second wave of COVID-19 infections in the State.
- Pace of vaccination up: 10 crore doses administered in 24 days
The pace of Covid vaccination has increased significantly with India administering the latest 10 crore doses in just 24 days, taking the total coverage to over 41 crore doses given so far.
- Firm’s warm vaccine gets $4.2m funding boost
Mynvax, a vaccine technology startup, on Monday said it has signed definitive agreements to raise $4.2 million — around Rs 31 crore — in its Series A round of financing led by Accel.
- New variant to drive next Covid-19 wave
Over 80% of new cases of Covid-19 in India have been caused due to the Delta variant of the coronavirus which has now spread to 80 countries and the next wave will be driven by a variant to which significant proportion of population is susceptible, one of the government’s top health advisors has said.
- Jabs drive slows down as vaccine stocks fall short
The sluggish pace of immunisation continued in the Capital, with fewer than 26,000 doses of Covid-19 vaccines administered on Monday, when only 418 of the city’s 1,374 vaccination sites were open, with jab stocks still low.